✦ LIBER ✦

256 Peginterferon Alpha-2a Plus Adefovir Dipivoxil vs. Peginterferon Alpha-2a Monotherapy for 48 Weeks in HBeAg-Negative Chronic Hepatitis B: Final Results of the PEG for B Randomized Multicenter Trial

✍ Scribed by Piccolo, Paola; De Melia, Luigi; Bandiera, Franco; Piras, Maria Rosaria; Antonucci, Giorgio; Nosotti, Lorenzo; Mari, Terenzio; De santis, Adriano; Ponti, Laura; Lenci, Ilaria; Di Paolo, Daniele; Telesca, Claudia; Sorbello, Orazio; Iacomi, Fabio; Cristofari, Francesca; Angelico, Mario

Book ID: 123084644
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 87 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)63553-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[54] PEGINTERFERON-ALPHA-2a PLUS ADEFOVI

[54] PEGINTERFERON-ALPHA-2a PLUS ADEFOVIR VS. PEGINTERFERON ALPHA-2a FOR 48 WEEKS IN HBeAg-NEGATIVE CHRONIC HEPATITIS B: PRELIMINARY 24-WEEK RESULTS OF THE PEG FOR B RANDOMIZED MULTICENTER TRIAL

✍ P. Piccolo; I. Lend; D. Di Paolo; C. Telesca; L. DeMelia; O. Sorbello; F. Bandie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 143 KB

43 A multicenter, randomized, open-label

43 A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of chinese patients with HBeAg+VE chronic hepatitis B

✍ H. Zhao; C.-W. Si; L. Wei; M.-B. Wan; Y.-K. Ying; J.-L. Hou; J.-Q. Niu; G.-Q. Wa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 257 KB

734 Peginterferon alpha-2a (PEGASYS) plu

734 Peginterferon alpha-2a (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks in patients with HCV genotype 2 OR 3. Final results of the accelerate trial

✍ M.L. Shiffman; S. Pappas; L. Nyberg; S. Greenbloom; A. Gibas; B. Bacons; J. Rase 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Sa1055 Final Results of a Clinical Trial

Sa1055 Final Results of a Clinical Trial of a 2-Week Lead-in Therapy With Interferon Beta Plus Ribavirin Before Peginterferon alpha-2B Plus Ribavirin for Chronic Hepatitis C With Genotype 1 and High Viral Loads

✍ Sato, Ken; Ohyama, Tatsuya; Hashizume, Hiroaki; Horiguchi, Norio; Yamazaki, Yuic 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

PGI24 Cost-Effectiveness Analysis of 48-

PGI24 Cost-Effectiveness Analysis of 48-Week Peginterferon Alpha-2a Under RGT Strategy Versus 3 Years Entecavir for the Treatment of HBeAg-Positive Chronic Hepatitis B in China

✍ W. Zhang; H. Zhuang; H. Ren; X. Dou; W. Chen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

95 Peginterferon alfa-2A (40KD) (PEGASYS

95 Peginterferon alfa-2A (40KD) (PEGASYS®) monotherapy is more effective than lamivudine monotherapy in the treatment of HBEAG-negative chronic hepatitis B: 72-week results from a phase III, partially double-blind study of PEGASYS® alone vs PEGASYS® plus lamivudine vs lamivudine

✍ P. Marcellin; G.K.K. Lau; F. Bonino; P. Farci; S. Hadziyannis; R. Jin; Z.-M. Lu; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB